{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:17:39Z","timestamp":1761686259723,"version":"build-2065373602"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00108-025-01976-4","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:00:29Z","timestamp":1757415629000},"page":"1164-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Helicobacter pylori"],"prefix":"10.1007","volume":"66","author":[{"given":"Christian","family":"Schulz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Sch\u00fctte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"1976_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1055\/s-0043-106311","volume":"55","author":"C Franck","year":"2017","unstructured":"Franck\u00a0C, Hoffmann\u00a0A, Link\u00a0A et\u00a0al (2017) Prevalence of Helicobacter pylori infection among blood donors in Saxony-Anhalt, Germany\u2014a\u00a0region at intermediate risk for gastric cancer. Z\u00a0Gastroenterol 55:653\u2013656","journal-title":"Z Gastroenterol"},{"key":"1976_CR2","doi-asserted-by":"crossref","unstructured":"Macke L (2023) HelicoPTER \u2013 lokale Pr\u00e4valenz, Therapieerfolg und Antibiotikaresistenz der Helicobacter pylori-Infektion in Deutschland. Z\u00a0Gastroenterol 61","DOI":"10.1055\/s-0043-1771658"},{"key":"1976_CR3","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1128\/CVI.05308-11","volume":"18","author":"T Wex","year":"2011","unstructured":"Wex\u00a0T, Venerito\u00a0M, Kreutzer\u00a0J et\u00a0al (2011) Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010. Clin Vaccine Immunol 18:2109\u20132112","journal-title":"Clin Vaccine Immunol"},{"key":"1976_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1055\/a-2207-7185","volume":"62","author":"C Schulz","year":"2024","unstructured":"Schulz\u00a0C, Schutte\u00a0K, Link\u00a0A et\u00a0al (2024) 1983\u20132023\u2014Four decades Helicobacter pylori\u2014what\u2019s next? Z\u00a0Gastroenterol 62:512\u2013516","journal-title":"Z Gastroenterol"},{"key":"1976_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner\u00a0P, Camargo\u00a0MC, El-Omar\u00a0E et\u00a0al (2023) Helicobacter pylori infection. Nat Rev Dis Primers 9:19","journal-title":"Nat Rev Dis Primers"},{"key":"1976_CR6","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer\u00a0M, De Martel\u00a0C, Vignat\u00a0J et\u00a0al (2016) Global burden of cancers attributable to infections in 2012: a\u00a0synthetic analysis. Lancet Glob Health 4:e609\u2013616","journal-title":"Lancet Glob Health"},{"key":"1976_CR7","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.14309\/ctg.0000000000000127","volume":"11","author":"DS Choi","year":"2020","unstructured":"Choi\u00a0DS, Seo\u00a0SI, Shin\u00a0WG et\u00a0al (2020) Risk for Colorectal Neoplasia in Patients With Helicobacter pylori Infection: A\u00a0Systematic Review and Meta-analysis. Clin Transl Gastroenterol 11:e127","journal-title":"Clin Transl Gastroenterol"},{"key":"1976_CR8","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1200\/JCO.23.00703","volume":"42","author":"SC Shah","year":"2024","unstructured":"Shah\u00a0SC, Camargo\u00a0MC, Lamm\u00a0M et\u00a0al (2024) Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a\u00a0Large, Nationwide Cohort. J\u00a0Clin Oncol 42:1881\u20131889","journal-title":"J Clin Oncol"},{"key":"1976_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/a-2181-2225","volume":"62","author":"W Fischbach","year":"2024","unstructured":"Fischbach\u00a0W, Bornschein\u00a0J, Hoffmann\u00a0JC et\u00a0al (2024) Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Z\u00a0Gastroenterol 62:261\u2013321","journal-title":"Z Gastroenterol"},{"key":"1976_CR10","first-page":"CD003840","volume":"4","author":"AC Ford","year":"2016","unstructured":"Ford\u00a0AC, Gurusamy\u00a0KS, Delaney\u00a0B et\u00a0al (2016) Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev 4:CD3840","journal-title":"Cochrane Database Syst Rev"},{"key":"1976_CR11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","volume":"396","author":"AC Ford","year":"2020","unstructured":"Ford\u00a0AC, Mahadeva\u00a0S, Carbone\u00a0MF et\u00a0al (2020) Functional dyspepsia. Lancet 396:1689\u20131702","journal-title":"Lancet"},{"key":"1976_CR12","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Megraud F, Rokkas T et\u00a0al (2022) Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut","DOI":"10.1136\/gutjnl-2022-327745"},{"key":"1976_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/gut.2010.207662","volume":"60","author":"T Hagiwara","year":"2011","unstructured":"Hagiwara\u00a0T, Mukaisho\u00a0K, Nakayama\u00a0T et\u00a0al (2011) Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut 60:624\u2013630","journal-title":"Gut"},{"key":"1976_CR14","doi-asserted-by":"publisher","first-page":"175628481989406","DOI":"10.1177\/1756284819894062","volume":"12","author":"C Schulz","year":"2019","unstructured":"Schulz\u00a0C, Schutte\u00a0K, Mayerle\u00a0J et\u00a0al (2019) The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond. Therap Adv Gastroenterol 12:1756284819894062","journal-title":"Therap Adv Gastroenterol"},{"key":"1976_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1055\/a-2529-5025","volume":"57","author":"M Dinis-Ribeiro","year":"2025","unstructured":"Dinis-Ribeiro\u00a0M, Libanio\u00a0D, Uchima\u00a0H et\u00a0al (2025) Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025. Endoscopy 57:504\u2013554","journal-title":"Endoscopy"},{"key":"1976_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1158\/1055-9965.EPI-06-0758","volume":"16","author":"YC Lee","year":"2007","unstructured":"Lee\u00a0YC, Lin\u00a0JT, Wu\u00a0HM et\u00a0al (2007) Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev 16:875\u2013885","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1976_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa1909666","volume":"382","author":"IJ Choi","year":"2020","unstructured":"Choi\u00a0IJ, Kim\u00a0CG, Lee\u00a0JY et\u00a0al (2020) Family History of Gastric Cancer and Helicobacter pylori Treatment. N\u00a0Engl J Med 382:427\u2013436","journal-title":"N Engl J Med"},{"key":"1976_CR18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","volume":"378","author":"IJ Choi","year":"2018","unstructured":"Choi\u00a0IJ, Kook\u00a0MC, Kim\u00a0YI et\u00a0al (2018) Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. N\u00a0Engl J Med 378:1085\u20131095","journal-title":"N Engl J Med"},{"key":"1976_CR19","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1053\/j.gastro.2022.02.027","volume":"162","author":"SF Moss","year":"2022","unstructured":"Moss\u00a0SF, Dang\u00a0LP, Chua\u00a0D et\u00a0al (2022) Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing. Gastroenterology 162:2095\u20132097 e2092","journal-title":"Gastroenterology"},{"key":"1976_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","volume":"64","author":"K Sugano","year":"2015","unstructured":"Sugano\u00a0K, Tack\u00a0J, Kuipers\u00a0EJ et\u00a0al (2015) Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64:1353\u20131367","journal-title":"Gut"},{"key":"1976_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","volume":"377","author":"P Malfertheiner","year":"2011","unstructured":"Malfertheiner\u00a0P, Bazzoli\u00a0F, Delchier\u00a0JC et\u00a0al (2011) Helicobacter pylori eradication with a\u00a0capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a\u00a0randomised, open-label, non-inferiority, phase\u00a03\u00a0trial. Lancet 377:905\u2013913","journal-title":"Lancet"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01976-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01976-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01976-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:03:27Z","timestamp":1761678207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01976-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01976-4","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"31 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"C.\u00a0Schulz:\n                      A.\u00a0Finanzielle Interessen: JUVISE (franz\u00f6sisches Pharmaunternehmen): Vortragshonorar, Adboard-Honorar.\u00a0\u2013 JUVISE (franz\u00f6sischer Pharmahersteller): Mitarbeiterschulung Au\u00dfendienst.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Stellvertretender Klinikdirektor LMU Klinikum M\u00fcnchen | Leitlinienkoordinator\n                      Helicobacter pylori-\n                      Leitlinie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS); Board member European Helicobacter and Mikrobiota Study Group (EHMSG); Member Education Committee (Educom; Weiterbildungsgruppe der europ\u00e4ischen Fachgesellschaft United European Gastroenterology [UEG]); Scientific secretary European Consensus\n                      H.\u00a0pylori\n                      Management Maastricht\u00a0VI.\n                      K.\u00a0Sch\u00fctte:\n                      A.\u00a0Finanzielle Interessen: Referentenhonorar f\u00fcr Vortrag durch die Firma JUVISE.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellt als Chef\u00e4rztin der Klinik f\u00fcr Innere Medizin, Gastroenterologie und Diabetologie, Niels-Stensen-Kliniken Marienhospital Osnabr\u00fcck | Mitgliedschaften: DGVS, Norddeutsche Gesellschaft f\u00fcr Gastroenterologie (NDGG; hier im Vorstand), Arbeitsgemeinschaft leitender gastroenterologischer Krankenhaus\u00e4rztinnen und -\u00e4rzte (ALGK; im Vorstand), Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), EHMSG.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}